Carisma Therapeutics (CARM) Stock Chart & Stock Price History → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free CARM Stock Alerts $1.48 -0.03 (-1.99%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Carisma Therapeutics Stock Price Performance5 Day Performance-7.21%1 Month Performance-25.25%3 Month Performance-29.86%6 Month Performance-38.20%Year-To-Date Performance-49.49%1 Year Performance-73.81% Receive CARM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad OIC[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueJoin us for an exploration of essential volatility concepts in our "Volatility Fundamentals II: Skew & Relative Value" session. OIC® instructor Ken Keating will guide you through important topics that options investors should understand. Click here to register now (5/15 Webinar) CARM Stock Chart for Sunday, May, 12, 2024 CARM Chart by TradingView Carisma Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$1.51$1.48-1.99%$1.51$1.43203,037 shs$61.48 million05/09/2024$1.55$1.51-2.58%$1.54$1.47185,019 shs$62.73 million05/08/2024$1.55$1.55$1.61$1.52132,276 shs$64.39 million05/07/2024$1.60$1.55-2.82%$1.61$1.55115,399 shs$64.39 million05/06/2024$1.62$1.60-1.54%$1.66$1.58121,123 shs$66.26 million05/03/2024$1.60$1.62+1.25%$1.67$1.59119,269 shs$67.30 million Get the Latest News and Ratings for CARM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$1.63$1.60-1.84%$1.66$1.53163,645 shs$66.46 million05/01/2024$1.63$1.63$1.67$1.6097,631 shs$67.72 million04/30/2024$1.67$1.63-2.40%$1.68$1.6291,241 shs$67.71 million04/29/2024$1.64$1.67+1.83%$1.71$1.60118,059 shs$69.37 million04/26/2024$1.64$1.64$1.70$1.6054,549 shs$68.13 million04/25/2024$1.68$1.64-2.38%$1.69$1.60112,325 shs$68.13 million04/24/2024$1.70$1.68-1.18%$1.77$1.6750,914 shs$69.79 million04/23/2024$1.87$1.70-9.09%$1.91$1.68125,467 shs$70.62 million04/22/2024$1.63$1.87+14.72%$1.87$1.64143,170 shs$77.69 million04/19/2024$1.71$1.63-4.68%$1.73$1.53256,569 shs$67.71 million04/18/2024$1.69$1.71+1.18%$1.75$1.66172,530 shs$71.03 million04/17/2024$1.70$1.69-0.59%$1.77$1.65215,000 shs$70.21 million04/16/2024$1.76$1.70-3.41%$1.79$1.65193,038 shs$70.62 million04/15/2024$1.93$1.76-8.81%$1.98$1.71190,598 shs$73.11 million04/12/2024$1.98$1.93-2.53%$1.99$1.88217,650 shs$80.17 million04/11/2024$1.91$1.98+3.66%$2.04$1.93176,088 shs$82.25 million04/10/2024$1.98$1.91-3.54%$1.94$1.83170,168 shs$79.34 million04/09/2024$2.01$1.98-1.49%$2.05$1.86164,603 shs$82.25 million04/08/2024$1.82$2.01+10.44%$2.03$1.85230,817 shs$83.50 million04/05/2024$1.92$1.82-5.21%$1.97$1.80189,118 shs$75.60 million04/04/2024$1.97$1.92-2.54%$2.00$1.89231,927 shs$79.76 million04/03/2024$2.01$1.97-1.99%$2.04$1.86264,069 shs$79.50 million04/02/2024$2.09$2.01-3.83%$2.14$1.97273,850 shs$81.12 million04/01/2024$2.27$2.09-7.93%$2.30$1.98332,358 shs$84.35 million03/29/2024$2.27$2.27$2.36$2.23181,757 shs$91.62 million03/28/2024$2.24$2.27+1.34%$2.36$2.23181,262 shs$91.61 million03/27/2024$2.30$2.24-2.61%$2.39$2.24232,590 shs$90.41 million03/26/2024$2.52$2.30-8.73%$2.60$2.30207,791 shs$92.83 million03/25/2024$2.44$2.52+3.28%$2.56$2.41172,745 shs$101.71 million03/22/2024$2.51$2.44-2.79%$2.66$2.43175,162 shs$98.48 million03/21/2024$2.54$2.51-1.18%$2.60$2.49119,442 shs$101.30 million03/20/2024$2.32$2.54+9.48%$2.58$2.27154,845 shs$102.51 million03/19/2024$2.27$2.32+2.20%$2.38$2.25106,884 shs$93.64 million03/18/2024$2.32$2.27-2.16%$2.43$2.25100,000 shs$91.62 millionThe Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him03/15/2024$2.47$2.32-6.07%$2.49$2.30249,474 shs$93.64 million03/14/2024$2.58$2.47-4.26%$2.63$2.45168,252 shs$99.68 million03/13/2024$2.44$2.58+5.74%$2.64$2.40164,604 shs$104.13 million03/12/2024$2.41$2.44+1.24%$2.65$2.43198,665 shs$98.48 million03/11/2024$2.25$2.41+7.11%$2.52$2.23109,021 shs$97.27 million03/08/2024$2.48$2.25-9.27%$2.62$2.23102,456 shs$90.81 million03/07/2024$2.60$2.48-4.62%$2.67$2.4552,357 shs$100.09 million03/06/2024$2.60$2.60$2.63$2.51122,327 shs$104.94 million03/05/2024$2.58$2.60+0.78%$2.61$2.46117,926 shs$104.94 million03/04/2024$2.59$2.58-0.39%$2.65$2.55143,301 shs$104.12 million03/01/2024$2.58$2.59+0.39%$2.76$2.55234,539 shs$104.53 million02/29/2024$2.55$2.58+1.18%$2.64$2.52169,439 shs$104.13 million02/28/2024$2.54$2.55+0.39%$2.60$2.45298,476 shs$102.92 million02/27/2024$2.53$2.54+0.40%$2.60$2.41233,084 shs$102.51 million02/26/2024$2.42$2.53+4.55%$2.57$2.40187,123 shs$102.11 million02/23/2024$2.48$2.42-2.42%$2.55$2.26172,814 shs$97.67 million02/22/2024$2.45$2.48+1.22%$2.58$2.44158,726 shs$100.09 million02/21/2024$2.41$2.45+1.66%$2.57$2.41306,654 shs$98.88 million02/20/2024$2.30$2.41+4.78%$2.45$2.25208,629 shs$97.27 million02/19/2024$2.30$2.30$2.34$2.2578,700 shs$92.82 million02/16/2024$2.29$2.30+0.44%$2.34$2.2578,655 shs$92.83 million02/15/2024$2.13$2.29+7.51%$2.31$2.13106,368 shs$92.42 million02/14/2024$2.07$2.13+2.90%$2.20$2.0788,423 shs$85.96 million02/13/2024$2.26$2.07-8.41%$2.40$2.05159,955 shs$83.55 million02/12/2024$2.11$2.26+7.11%$2.40$2.11218,813 shs$91.21 million Related Companies: Mural Oncology Stock Price Chart MediciNova Stock Price Chart Kronos Bio Stock Price Chart Equillium Stock Price Chart Viveon Health Acquisition Stock Price Chart Aileron Therapeutics Stock Price Chart Eagle Pharmaceuticals Stock Price Chart Kezar Life Sciences Stock Price Chart Checkpoint Therapeutics Stock Price Chart Journey Medical Stock Price Chart Receive CARM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Carisma Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CARM) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsCollapse of the Petrodollar Colonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe Exchange[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carisma Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.